(45 days)
21.3-inch (54cm) Color LCD Monitor CDL2120A (CCL252i2) is to be used in displaying and viewing medical images for diagnosis by trained medical practitioners. It is not meant to be used for digital mammography.
CDL2120A (CCL252i2) is a 21.3-inch Color LCD Monitor that supports DVI video signal and provides UXGA (1600 x 1200) resolution for both landscape and portrait display.
This 510(k) summary is for a medical display monitor and as such, it does not involve an AI/ML algorithm or a study comparing AI with human readers. The acceptance criteria for such a device typically relate to its technical specifications and performance characteristics, rather than diagnostic accuracy determined by a study involving a test set, ground truth, or expert readers as would be the case for an AI diagnostic tool.
Therefore, many of the requested sections (2, 3, 4, 5, 6, 7, 8, 9) are not applicable to the provided document.
Here's the relevant information that can be extracted:
Acceptance Criteria and Device Performance:
The document doesn't explicitly state "acceptance criteria" in the format of a table with specific thresholds. However, the core of the substantial equivalence claim for this monitor lies in its technical specifications being comparable to the predicate device. The performance is implied by these specifications.
1. A table of acceptance criteria and the reported device performance:
| Feature/Characteristic | Acceptance Criteria (Implied by equivalence to predicate) | Reported Device Performance (CDL2120A / CCL252i2) |
|---|---|---|
| Display Size | 21.3-inch (54cm) | 21.3-inch (54cm) |
| Display Type | Color LCD Monitor | Color LCD Monitor |
| Video Signal Support | DVI video signal | Supports DVI video signal |
| Resolution | UXGA (1600 x 1200) | UXGA (1600 x 1200) |
| Display Orientation | Landscape and portrait | Both landscape and portrait display |
| Intended Use | Displaying and viewing medical images for diagnosis by trained medical practitioners. Not for digital mammography. | Displaying and viewing medical images for diagnosis by trained medical practitioners. Not meant to be used for digital mammography. |
| Key Differentiating Feature from Predicate | Not applicable (predicate does not have this feature) | Newly-developed luminance equalizer |
Sections not applicable for this device and document:
- Sample size used for the test set and the data provenance (e.g. country of origin of the data, retrospective or prospective): Not applicable. This is a display monitor, not a diagnostic algorithm evaluated on a data set.
- Number of experts used to establish the ground truth for the test set and the qualifications of those experts (e.g. radiologist with 10 years of experience): Not applicable.
- Adjudication method (e.g. 2+1, 3+1, none) for the test set: Not applicable.
- If a multi reader multi case (MRMC) comparative effectiveness study was done, If so, what was the effect size of how much human readers improve with AI vs without AI assistance: Not applicable. This is not an AI device.
- If a standalone (i.e. algorithm only without human-in-the-loop performance) was done: Not applicable. This is not an algorithm.
- The type of ground truth used (expert consensus, pathology, outcomes data, etc): Not applicable.
- The sample size for the training set: Not applicable.
- How the ground truth for the training set was established: Not applicable.
Summary of the Study/Basis for Substantial Equivalence:
The provided document indicates that the device, CDL2120A (CCL252i2), achieved substantial equivalence based on a comparison to a predicate device, CDL2113A ([K050616](https://510k.innolitics.com/search/K050616)). The "study" here is not a clinical trial with patient data, but rather a technical comparison and verification that the new monitor meets the necessary performance standards for its intended use and is functionally equivalent to a device already cleared for market. The only stated difference is the "newly-developed luminance equalizer," which implies that the technical performance of this equalizer, along with other core display characteristics, was evaluated against established industry and regulatory standards for medical displays, or demonstrated to not raise new questions of safety or effectiveness compared to the predicate.
{0}------------------------------------------------
DEC - 4 2006_
:
:
!
:
:
510(k) SUMMARY
| Submitter Information: | TOTOKU ELECTRIC CO., LTD.300 Oya, UedaNagano 386-0192 Japan |
|---|---|
| Contact Person: | Mikio Hasegawa, General ManagerEmail: hasegawam@totoku.co.jpTel:+81.268.34.5469Fax:+81.268.34.5548 |
| Date Prepared: | October 17, 2006 |
| Device Name: | 21.3-inch (54cm) Color LCD Monitor CDL2120A (CCL252i2) |
| Common Name: | CDL2120A, CCL252i2, 2M Monitor/Display |
| Classification Name: | Class II(Part 892 Radiology DevicesSec. 892.2050 Picture Archiving and Communication System) |
| Predicate Device: | CDL2113A (K050616) |
| Device Description: | CDL2120A (CCL252i2) is a 21.3-inch Color LCD Monitor thatsupports DVI video signal and provides UXGA (1600 x 1200)resolution for both landscape and portrait display. |
| Intended Use: | 21.3-inch (54cm) Color LCD Monitor CDL2120A (CCL252i2) is tobe used in displaying and viewing medical images for diagnosis bytrained medical practitioners. It is not meant to be used for digitalmammography. |
| Substantial Equivalence: | CDL2120A (CCL252i2) shares the same characteristics with ourpredicate device CDL2113A (K050616) except for the newly-developed luminance equalizer. |
300 Oya, Ueda, Nagano 386-0192 Japan
{1}------------------------------------------------
Image /page/1/Picture/1 description: The image shows a circular seal with text around the perimeter and a stylized eagle in the center. The text reads "DEPARTMENT OF HEALTH & HUMAN SERVICES - USA". The eagle is depicted with three curved lines representing its wings and two wavy lines representing its legs.
Food and Drug Administration 9200 Corporate Blvd. Rockville MD 20850
2006 DEC 4
Mr. Mikio Hasegawa General Manager TOTOKU Electric Co., Ltd. MM Company, Design Group 300 Oya, Ueda, Nagano 386-0192 JAPAN
Re: K063199
Trade/Device Name: 21.3-inch (54cm) Color LCD Monitor CDL2120A (CCL252i2) Regulation Number: 21 CFR 892.2050 Regulation Name: Picture archiving and communications system Regulatory Class: II Product Code: LLZ Dated: October 17, 2006 Received: October 20, 2006
Dear Mr. Hasegawa:
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration.
If your device is classified (see above) into either class II (Special Controls) or class III (Premarket Approval), it may be subject to such additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.
Image /page/1/Picture/10 description: The image is a circular logo with the text "1926-2026" at the top. Below the text is a large "PA" in bold letters. Underneath "PA" is the word "Centennial" in a cursive font. There are three stars at the bottom of the logo.
Protecting and Promoting Public Health
{2}------------------------------------------------
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.
This letter will allow you to begin marketing your device as described in your Section 510/k) premarket notification. The FDA finding of substantial equivalence of your device to a legally marketed predicate device results in a classification for your device and thus, permits your device to proceed to the market.
If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please contact the Office of Compliance at one of the following numbers, based on the regulation number at the top of this letter:
| 21 CFR 876.xxx | (Gastroenterology/Renal/Urology) | 240-276-0115 |
|---|---|---|
| 21 CFR 884.xxx | (Obstetrics/Gynecology) | 240-276-0115 |
| 21 CFR 894.xxx | (Radiology) | 240-276-0120 |
| Other | 240-276-0100 |
Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21CFR Part 807.97). You may obtain other general information on your responsibilities under the Act from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or (240) 276-3150
or at its Internet address http://www.fda.gov/cdrl/industry/support/index.html.
Sincerely yours,
Nancy C. Hogdon
Nancy C. Brogdon Director, Division of Reproductive, Abdominal, and Radiological Devices Office of Device Evaluation Center for Devices and Radiological Health
Enclosure
Page 2 -
{3}------------------------------------------------
INDICATIONS FOR USE
510(k) Number: Not Known
Device Name: 21.3-inch (54cm) Color LCD Monitor CDL2120A (CCL252i2) Indications for Use:
21.3-inch (54cm) Color LCD Monitor CDL2120A (CCL252i2) is to be used in displaying and viewing medical images for diagnosis by trained medical practitioners. It is not meant to be used for digital mammography.
Prescription Use (Part 21 CFR 801 Subpart D)
AND/OR
Over-The-Counter Use (21 CFR 807 Subpart C)
(PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE OF NEEDED)
Concurrence of CDRH, Office of Device Evaluation (ODE)
Nancy Brogdon
and Radiological Devices 510(k) Numl
§ 892.2050 Medical image management and processing system.
(a)
Identification. A medical image management and processing system is a device that provides one or more capabilities relating to the review and digital processing of medical images for the purposes of interpretation by a trained practitioner of disease detection, diagnosis, or patient management. The software components may provide advanced or complex image processing functions for image manipulation, enhancement, or quantification that are intended for use in the interpretation and analysis of medical images. Advanced image manipulation functions may include image segmentation, multimodality image registration, or 3D visualization. Complex quantitative functions may include semi-automated measurements or time-series measurements.(b)
Classification. Class II (special controls; voluntary standards—Digital Imaging and Communications in Medicine (DICOM) Std., Joint Photographic Experts Group (JPEG) Std., Society of Motion Picture and Television Engineers (SMPTE) Test Pattern).